Characterization of Tissue-Specific Immune Responses to Bronchoscopic Instillation of Mycobacterial Antigens Into the Human Lung

NCT05027958 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

17

Enrollment

NIH

Sponsor class

Conditions

Healthy
Latent Tuberculosis Infection (LTBI)

Interventions

DRUG: Tuberculin Purified Protein Derivative

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)